Workshop Date and Time
Friday, May 29, 2020, 1:30 – 2:30 pm, Eastern Time Register Now
Registrants can listen in live over the phone or online as a webcast.
- Overview of the Treatment of Gastrointestinal Stromal Tumors (GIST), in the Context of COVID-19
- Diagnosis and Staging
- Treatment Options
- Clinical Trials and Novel Approaches to Treating GIST
- Strategies to Manage Common Treatment Side Effects, Discomfort and Pain
- The Importance of Communicating with Your Health Care Team
- What’s New on the Horizon for GIST Cancers
- Questions for Our Panel of Experts
Our Panel of Experts
Suzanne George, MD
Clinical Director, Center for Sarcoma and Bone Oncology, Senior Physician, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School
Michael C. Heinrich, MD
Professor of Medicine, Cell and Developmental Biology, Hematology and Medical Oncology, Program in Molecular and Cellular Biosciences, School of Medicine, Oregon Health & Science University (OHSU)
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
CancerCare, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).
To request continuing education paperwork, please email your name, profession, and address to email@example.com after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.
You can download the brochure for this workshop(68.2 KB)